研究单位：[1]Xuanwu Hospital, Beijing[2]Zhongshan Hospital, Xiamen University,Xiamen, Fujian, China[3]Nanfang Hospital, Southern Medical University,Guangzhou, Guangdong, China[4]Xiangya Hospital, Central South University,Changsha, Hunan, China[5]Xijing Hospital,Shanxi, Xi'an, China[6]The First People's Hospital of Yunnan Province,Kunming, Yunnan, China
研究目的：
Although generalized convulsive status epilepticus (GCSE) is a life-threatening emergency, evidence-based data to guide initial drug treatment choices are lacking in the Chinese population. The investigators conduct this prospective randomized controlled trial to evaluate the relative efficacy and safety of intravenous (IV) phenobarbital (PB) and valproate (VPA) in patients with GCSE.
